Coenzyme	coenzyme	CHEMICALS	O	OTHERS	I
Q10	q10	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
ameliorates	ameliorates	O	O	O	O
acute	acute	O	O	O	O
cisplatin	cisplatin	CHEMICALS	O	OTHERS	I
nephrotoxicity	nephrotoxicity	O	DISEASE	OTHERS	I
in	in	O	O	O	O
mice	mice	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
nephroprotective	nephroprotective	O	O	O	O
effect	effect	O	O	O	O
of	of	O	O	O	O
coenzyme	coenzyme	CHEMICALS	O	OTHERS	I
Q10	q10	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
investigated	investigated	O	O	O	O
in	in	O	O	O	O
mice	mice	O	O	O	O
with	with	O	O	O	O
acute	acute	O	DISEASE	OTHERS	I
renal	renal	O	DISEASE	OTHERS	I
injury	injury	O	DISEASE	OTHERS	I
induced	induced	O	O	O	O
by	by	O	O	O	O
a	a	O	O	O	O
single	single	O	O	O	O
i.p	i.p	O	O	O	O
.	.	O	O	O	O

injection	injection	O	O	O	O
of	of	O	O	O	O
cisplatin	cisplatin	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
5	5	O	O	O	O
mg/kg	mg/kg	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Coenzyme	coenzyme	CHEMICALS	O	OTHERS	I
Q10	q10	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
(	(	O	O	O	O
10	10	O	O	O	O
mg/kg/day	mg/kg/day	O	O	O	O
,	,	O	O	O	O
i.p	i.p	O	O	O	O
.	.	O	O	O	O
)	)	O	O	O	O
was	was	O	O	O	O
applied	applied	O	O	O	O
for	for	O	O	O	O
6	6	O	O	O	O
consecutive	consecutive	O	O	O	O
days	days	O	O	O	O
,	,	O	O	O	O
starting	starting	O	O	O	O
1	1	O	O	O	O
day	day	O	O	O	O
before	before	O	O	O	O
cisplatin	cisplatin	CHEMICALS	O	OTHERS	I
administration	administration	O	O	O	O
.	.	O	O	O	O

Coenzyme	coenzyme	CHEMICALS	O	OTHERS	I
Q10	q10	CHEMICALS	O	OTHERS	I
significantly	significantly	O	O	O	O
reduced	reduced	O	O	O	O
blood	blood	CHEMICALS	O	OTHERS	I
urea	urea	CHEMICALS	O	OTHERS	I
nitrogen	nitrogen	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
serum	serum	O	O	O	O
creatinine	creatinine	CHEMICALS	O	OTHERS	I
levels	levels	O	O	O	O
which	which	O	O	O	O
were	were	O	O	O	O
increased	increased	O	O	O	O
by	by	O	O	O	O
cisplatin	cisplatin	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Coenzyme	coenzyme	CHEMICALS	O	OTHERS	I
Q10	q10	CHEMICALS	O	OTHERS	I
significantly	significantly	O	O	O	O
compensated	compensated	O	O	O	O
deficits	deficits	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
antioxidant	antioxidant	O	O	O	O
defense	defense	O	O	O	O
mechanisms	mechanisms	O	O	O	O
(	(	O	O	O	O
reduced	reduced	O	O	OTHERS	I
glutathione	glutathione	CHEMICALS	O	OTHERS	I
level	level	O	O	O	O
and	and	O	O	O	O
superoxide	superoxide	CHEMICALS	O	OTHERS	I
dismutase	dismutase	CHEMICALS	O	OTHERS	I
activity	activity	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
suppressed	suppressed	O	O	O	O
lipid	lipid	O	O	O	O
peroxidation	peroxidation	O	O	O	O
,	,	O	O	O	O
decreased	decreased	O	O	O	O
the	the	O	O	O	O
elevations	elevations	O	O	O	O
of	of	O	O	O	O
tumor	tumor	O	DISEASE	OTHERS	I
necrosis	necrosis	O	DISEASE	OTHERS	I
factor-alpha	factor-alpha	O	O	O	O
,	,	O	O	O	O
nitric	nitric	CHEMICALS	O	OTHERS	I
oxide	oxide	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
platinum	platinum	O	O	OTHERS	I
ion	ion	O	O	O	O
concentration	concentration	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
attenuated	attenuated	O	O	O	O
the	the	O	O	O	O
reductions	reductions	O	O	O	O
of	of	O	O	O	O
selenium	selenium	O	O	OTHERS	I
and	and	O	O	O	O
zinc	zinc	O	O	OTHERS	I
ions	ions	O	O	O	O
in	in	O	O	O	O
renal	renal	O	O	O	O
tissue	tissue	O	O	O	O
resulted	resulted	O	O	O	O
from	from	O	O	O	O
cisplatin	cisplatin	CHEMICALS	O	OTHERS	I
administration	administration	O	O	O	O
.	.	O	O	O	O

Also	also	O	O	O	O
,	,	O	O	O	O
histopathological	histopathological	O	O	O	O
renal	renal	O	O	OTHERS	I
tissue	tissue	O	O	OTHERS	I
damage	damage	O	O	OTHERS	I
mediated	mediated	O	O	O	O
by	by	O	O	O	O
cisplatin	cisplatin	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
ameliorated	ameliorated	O	O	O	O
by	by	O	O	O	O
coenzyme	coenzyme	CHEMICALS	O	OTHERS	I
Q10	q10	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
.	.	O	O	O	O

Immunohistochemical	immunohistochemical	O	O	O	O
analysis	analysis	O	O	O	O
revealed	revealed	O	O	O	O
that	that	O	O	O	O
coenzyme	coenzyme	CHEMICALS	O	OTHERS	I
Q10	q10	CHEMICALS	O	OTHERS	I
significantly	significantly	O	O	O	O
decreased	decreased	O	O	O	O
the	the	O	O	O	O
cisplatin-induced	cisplatin-induced	O	O	O	O
overexpression	overexpression	O	O	O	O
of	of	O	O	O	O
inducible	inducible	O	O	O	O
nitric	nitric	CHEMICALS	O	OTHERS	I
oxide	oxide	CHEMICALS	O	OTHERS	I
synthase	synthase	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
nuclear	nuclear	O	O	O	O
factor-kappaB	factor-kappab	O	O	O	O
,	,	O	O	O	O
caspase-3	caspase-3	O	O	O	O
and	and	O	O	O	O
p53	p53	O	O	O	O
in	in	O	O	O	O
renal	renal	O	O	O	O
tissue	tissue	O	O	O	O
.	.	O	O	O	O

It	it	O	O	O	O
was	was	O	O	O	O
concluded	concluded	O	O	O	O
that	that	O	O	O	O
coenzyme	coenzyme	CHEMICALS	O	OTHERS	I
Q10	q10	CHEMICALS	O	OTHERS	I
represents	represents	O	O	O	O
a	a	O	O	O	O
potential	potential	O	O	O	O
therapeutic	therapeutic	O	O	O	O
option	option	O	O	O	O
to	to	O	O	O	O
protect	protect	O	O	O	O
against	against	O	O	O	O
acute	acute	O	O	O	O
cisplatin	cisplatin	CHEMICALS	O	OTHERS	I
nephrotoxicity	nephrotoxicity	O	DISEASE	OTHERS	I
commonly	commonly	O	O	O	O
encountered	encountered	O	O	O	O
in	in	O	O	O	O
clinical	clinical	O	O	O	O
practice	practice	O	O	O	O
.	.	O	O	O	O

